Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implications of fetoplacental mosaicism on cell‐free <scp>DNA</scp> testing: a review of a common biological phenomenon

31 May 2016

Abstract excerpt

Cell-free DNA (cfDNA) testing, also known as non-invasive prenatal testing/screening, for fetal aneuploidy is one of the most important technical advances in prenatal care and its uptake has increased rapidly. Practitioners offering this screening test must provide comprehensive pretest prenatal counseling, including the risk of possible discordances between cfDNA results and the ultrasound examination and/or the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Fetal and Pediatric Neurological Disorders
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27240559
DOI: 10.1002/uog.15975

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implications of fetoplacental mosaicism on cell‐free <scp>DNA</scp> testing: a review of a common biological phenomenonPMID 27240559Read ↗

Predicting fetoplacental mosaicism during cfDNA-based NIPTSemantic proximity Read ↗

Analysis of cell‐free <scp>DNA</scp> in maternal blood in screening for fetal aneuploidies: updated meta‐analysisSemantic proximity Read ↗

Implications of fetoplacental mosaicism on cell‐free DNA testing for sex chromosome aneuploidiesSemantic proximity Read ↗

Performance of Cell-Free DNA Sequencing-Based Non-invasive Prenatal Testing: Our Experience on 36456 both Singleton and Multiple Pregnancies.Semantic proximity Read ↗

Placental, maternal, fetal, and technical origins of false-positive cell-free DNA screening resultsSemantic proximity Read ↗

Advances in Prenatal Cell‐Free DNA Screening for Dominant Monogenic Conditions: A Review of Current Progress and Future Directions in Clinical ImplementationSemantic proximity Read ↗

Cell‐free <scp>DNA</scp> testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10–14 weeks and meta‐analysisSemantic proximity Read ↗

PREIMPLANTATION GENETIC TESTING: Non-invasive prenatal testing for aneuploidy, copy-number variants and single-gene disordersSemantic proximity Read ↗

Clinical Perspective of Cell-Free DNA Testing for Fetal AneuploidiesSemantic proximity Read ↗

Current controversies in prenatal diagnosis 2: Cell‐free DNA prenatal screening should be used to identify all chromosome abnormalitiesSemantic proximity Read ↗

Performance of non‐invasive prenatal testing when fetal cell‐free <scp>DNA</scp> is absentSemantic proximity Read ↗

Predicting fetoplacental chromosomal mosaicism during non‐invasive prenatal testingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.